Source: Health Canada shortage reports · Updated Jul 28, 2026
Some Sertraline products are in shortage in Canada (1 of 37 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antidepressant (SSRI) used to treat depression, anxiety and obsessive-compulsive disorder.
Products affected
1 / 37
In shortage since
Mar 17, 2017
Reports on file
158
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ACT SERTRALINE
25MG · CAPSULE · ACTAVIS PHARMA COMPANY
DIN 02287390 · since Mar 17, 2017, no end estimate · Disruption of the manufacture of the drug.
Anticipated
ZOLOFT
50MG · CAPSULE · BGP PHARMA ULC
DIN 01962817 · Disruption of the manufacture of the drug.
Anticipated
ZOLOFT
25MG · CAPSULE · BGP PHARMA ULC
DIN 02132702 · Disruption of the manufacture of the drug.
Anticipated
ZOLOFT
100MG · CAPSULE · BGP PHARMA ULC
DIN 01962779 · Disruption of the manufacture of the drug.
Anticipated
SERTRALINE
100MG · CAPSULE · SANIS HEALTH INC
DIN 02353547 · PACK SIZE DISCO. ALTERNATE PACK SIZE AVAILABLE
Resolved
TEVA-SERTRALINE
100MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240481 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-SERTRALINE
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240484 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
Resolved
SERTRALINE
25MG · CAPSULE · SANIS HEALTH INC
DIN 02353520 · ended Mar 4, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-SERTRALINE
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240484 · ended Feb 4, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-SERTRALINE
100MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240481 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-SERTRALINE
25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240485 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
Resolved
SERTRALINE
100MG · CAPSULE · SANIS HEALTH INC
DIN 02353547 · ended Aug 19, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Sertraline is currently affected by an active shortage report filed with Health Canada by ACTAVIS PHARMA COMPANY.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Sertraline is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
No changes recorded yet.
Common questions
What is Sertraline used for?
An antidepressant (SSRI) used to treat depression, anxiety and obsessive-compulsive disorder.
When will Sertraline be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Sertraline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.